Over forty million American men and twenty million American women suffer from androgenetic alopecia, aka common pattern hair loss. Pattern hair loss is by far the most common form, affecting more than ninety five percent of those who experience hair loss.
Unfortunately, although several viable treatment options exist, even today there is no cure for common hair loss.
From a treatment perspective, there are several clear choices which we’ll explore briefly now. The first choice is to cover the balding area with a wig or toupee. We can call these hair systems or hair replacement units. But in reality each consists of hair sewn or attached in some fashion to the skull. Constant maintenance is required to keep them looking reasonably natural. However, none are easy to maintain and most are quite uncomfortable. Also, by rubbing against the underlying scalp, whatever hair remains is soon shed. So the problem gets worse.
The next option is surgical hair transplantation. Here, viable hair bearing follicles are moved from permanent growing areas over and behind the ears to balding areas of the top frontal scalp. The advantage of this approach is the permanence of the result. Once transplanted, the hair follicles continue to produce viable hair, essentially for life. The disadvantages are primarily operator-related, meaning that an unnatural looking result may occur if the work is performed by a surgeon with limited artistic ability. The only thing worse than a balding scalp is a pluggy, misdirected field of poorly placed hair transplant grafts.
From a medical standpoint, two primary pharmaceutical choices are available. The first is minoxidil, originally used as a blood pressure medication and trademarked under various brand names including Rogaine™. Available in 2% and 5% extra strength solution, minoxidil has been shown to arrest and, in some cases reverse pattern hair loss. Interestingly, the mechanism of action behind minoxidil’s hair growth affect remains only partially understood. Because the treatment is derived from a highly potent vaso-modulating drug, the disadvantages of minoxidil include the potential for serious negative side effects including pulmonary embolism. Because of the potential for negative side effect, 5% minoxidil is not approved for use by women.
Another hair growth drug is finasteride, also known as Propecia™. Finasteride, originally developed to treat BPH (benign prostatic hyperplasia) was approved for use against pattern hair loss in the mid-1990’s. The drug operates by modifying the endogenous levels of 5 alpha reductase, a key step in the conversion of testosterone to its problematic metabolite dihydrotestosterone. Never approved for use by women, Recent claims of serious side effects, including loss of libido, gynecomastia and other problems have been raised.
The last treatment option available today involves the use of naturally-derived substances designed to block the underlying factors which cause pattern hair loss to occur. Unfortunately, most PRODUCTS advertised in this category fail to support their claims with any objective data. There is one treatment choice which can point to the highest level of empirical evidence to support its product claims. That product line is HairGenesi®.
Developed by a team of research professionals and led by a Ph.D. expert with more than twenty years experience in the hair loss treatment field, HairGenesis® stands alone. With a track record of 100% safety, HairGenesis® may be successfully used in its maximum strength formula by women as well as men.
Multiple peer-reviewed studies show that HairGenesis® works as advertised. HairGenesis® is also the only hair loss treatment, either naturally-based or drug-derived to demonstrate a dual mechanism of action. This is important because HairGenesis™ treats more than one cause of pattern hair loss — and pattern hair loss is caused by more than one thing.